ABBOTT DIABETES CARE INC

Abbott Diabetes Care Inc. specializes in the design, development, and manufacturing of diagnostic medical devices and associated technologies for diabetes management. Leveraging its expertise in biomedical engineering and in vitro diagnostics, the company focuses on glucose monitoring systems, insulin delivery platforms, and integrated data analytics solutions that support real-time patient care. Its technical capabilities include miniaturized sensor fabrication, electrochemical assay development, wireless telemetry, and FDA-regulated software validation for Class II medical devices. The firm’s key differentiators lie in its precision engineering of point-of-care diagnostics, closed-loop system integration, and adherence to ISO 13485 quality management standards for medical device production. Award history is not available to determine specific agency relationships or contract patterns. Consequently, no definitive agency experience can be inferred from the provided data. The primary NAICS code 325413 corresponds to the manufacturing of in vitro diagnostic substances and devices, indicating the company’s core focus on producing medical diagnostic equipment rather than pharmaceuticals or biologics. This positions Abbott Diabetes Care within the medical device manufacturing vertical, with specialization in chronic disease monitoring technologies. The company operates within a highly regulated environment requiring compliance with FDA 21 CFR Part 820 and ISO 14971 risk management standards. Abbott Diabetes Care Inc. is structured as a 2L entity, indicating a large, established corporate organization with significant operational scale. Headquartered in Alameda, California, the company maintains a strong presence in the U.S. government medical supply market through its regulated product lines, though no government certifications are listed. Its market positioning is defined by engineering excellence in durable, clinically validated diabetes care solutions rather than federal contracting activity.